Elispot Igra With Purified Protein Derivative Stimulation For Diagnosing Nontuberculous Mycobacterial Cervical Lympadenitis

被引：5

作者：

Kontturi, Antti ^{[1
,2
]}

Tuuminen, Tamara ^{[3
,4
]}

Karttunen, Riitta ^{[4
,5
]}

Salo, Eeva ^{[1
,2
]}

机构：

[1] Univ Helsinki, Childrens Hosp, PB 281, Helsinki, Finland

[2] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland

[3] Mikkeli Dist Lab, Eastern Finland Lab Ctr Joint Author Enterprise I, Mikkeli, Finland

[4] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki 00029, Finland

[5] Univ Helsinki, Cent Hosp, Lab Div HUSLAB, Helsinki 00029, Finland

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2016年 / 35卷 / 03期

关键词：

nontuberculous mycobacterial infection; childhood cervical lymphadenitis; NTM; CERVICOFACIAL LYMPHADENITIS; TUBERCULIN;

D O I：

10.1097/INF.0000000000000998

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Childhood cervical lymphadenitis caused by nontuberculous mycobacteria is a diagnostic challenge for the clinician. We present a new promising diagnostic method for childhood nontuberculous mycobacterial lymphadenitis. The modified T-SPOT.TB test with purified protein derivative as an additional antigen is noninvasive with estimated sensitivity and specificity of 1.00 and 0.81, respectively.

引用

页码：349 / 351

页数：3

共 10 条

[1] Common Presentations of Nontuberculous Mycobacterial Infections
Hatzenbuehler, Lindsay A.
Starke, Jeffrey R.
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (01) : 89 - 91
[2] Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children
Lindeboom, Jerome A.
Kuijper, Ed J.
Prins, Jan M.
van Coppenraet, Elisabeth S. Bruijnesteijn
Lindeboom, Robert
[J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (12) : 1547 - 1551
[3] Conservative Wait-and-See Therapy Versus Antibiotic Treatment for Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children
Lindeboom, Jerome A.
[J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : 180 - 184
[4] Treatment options for nontuberculous mycobacterial adenitis in children
Loeffler, AM
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (10) : 957 - 958
[5] ATYPICAL MYCOBACTERIA IN EXTRAPULMONARY DISEASE AMONG CHILDREN - INCIDENCE IN SWEDEN FROM 1969 TO 1990, RELATED TO CHANGING BCG-VACCINATION COVERAGE
ROMANUS, V
HALLANDER, HO
WAHLEN, P
OLINDERNIELSEN, AM
MAGNUSSON, PHW
JUHLIN, I
[J]. TUBERCLE AND LUNG DISEASE, 1995, 76 (04): : 300 - 310
[6] Management of lymphadenitis due to non-tuberculous mycobacterial infection in children
Scott, Catherine A.
Atkinson, Sarah H.
Sodha, Anisha
Tate, Christopher
Sadiq, Javaid
Lakhoo, Kokila
Pollard, Andrew J.
[J]. PEDIATRIC SURGERY INTERNATIONAL, 2012, 28 (05) : 461 - 466
[7] Algorithm for early diagnosis in nontuberculous mycobacterial lymphadenitis
Staufner, C.
Sommerburg, O.
Holland-Cunz, S.
[J]. ACTA PAEDIATRICA, 2012, 101 (08) : e382 - e385
[8] IGRA tests perform similarly to TST but cause no adverse reactions: Pediatric experience in Finland
Tavast E.
Salo E.
Seppälä I.
Tuuminen T.
[J]. BMC Research Notes, 2 (1)
[9] Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children
van Coppenraet, ESB
Lindeboom, JA
Prins, JM
Peeters, MF
Claas, ECJ
Kuijper, EJ
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) : 2644 - 2650
[10] Purified protein derivatives of tuberculin - past, present, and future
Yang, Hongliang
Kruh-Garcia, Nicole A.
Dobos, Karen M.
[J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2012, 66 (03): : 273 - 280

← 1 →